Serum microRNA Landscape in Eosinophilic Granulomatosis with Polyangiitis: A Hypothesis-Generating Reference Dataset

Introduction: Eosinophilic granulomatosis with polyangiitis (EGPA) is an eosinophilic vasculitis arising against a background of adult-onset asthma. We investigated circulating microRNA (miRNA) profiles in EGPA and integrated them with previously reported serum protein data. Methods: In this retrospective, cross-sectional study, archived sera from 14 patients with active, glucocorticoid-naïve EGPA and 20 with severe eosinophilic asthma without EGPA were profiled on a 2,588-miRNA microarray. Differential expression among 1,777 quantifiable miRNAs was assessed with limma, adjusting for sex and RNA integrity number; significance required both a Benjamini–Hochberg false discovery rate below 0.05 and a Bonferroni-corrected p below 0.05. TargetScan-predicted target genes were intersected with 29 serum proteins previously shown to differ between the same groups. Two further paired analyses, each performed in a separate group of patients with EGPA, compared active disease with the glucocorticoid-treated phase (n = 11) and samples before versus after mepolizumab (n = 13). Results: Eight miRNAs met both criteria: hsa-miR-3126-5p, hsa-miR-921, hsa-miR-6836-5p and hsa-miR-668-5p were lower in EGPA, and hsa-miR-6857-3p, hsa-miR-1260a, hsa-miR-603 and hsa-miR-12125 were higher (within-cohort areas under the curve, 0.82–0.94). Fourteen of the 29 proteins were encoded by predicted target genes. Only hsa-miR-3678-3p changed after glucocorticoid treatment; no miRNA changed after mepolizumab, and none of the eight EGPA-associated miRNAs changed with either treatment. Conclusion: This exploratory study identifies circulating miRNA differences between EGPA and severe eosinophilic asthma, and the complete result table is provided as a reference resource. Independent validation is required to establish their biological and clinical significance. Trial registration: UMIN000040163

Authors

Publication Details

Journal
International Archives of Allergy and Immunology
Published
2026-11-19
DOI
https://doi.org/10.1159/iaa/adfag045
Primary Topic
Vasculitis and related conditions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Serum microRNA Landscape in Eosinophilic Granulomatosis with Polyangiitis: A Hypothesis-Generating Reference Dataset

Kiyoshi Sekiya, Yosuke Kamide, Shigeharu Ueki, Kyuto Sonehara et al.
International Archives of Allergy and Immunology
Vasculitis and related conditions
article

Serum microRNA Landscape in Eosinophilic Granulomatosis with Polyangiitis: A Hypothesis-Generating Reference Dataset

Kiyoshi Sekiya, Yosuke Kamide, Shigeharu Ueki, Kyuto Sonehara, Masami Taniguchi, Yuma Fukutomi, Yoshihiro Furukawa, Yukinori Okada, Yuto Nakamura
article en

Abstract

Introduction: Eosinophilic granulomatosis with polyangiitis (EGPA) is an eosinophilic vasculitis arising against a background of adult-onset asthma. We investigated circulating microRNA (miRNA) profiles in EGPA and integrated them with previously reported serum protein data. Methods: In this retrospective, cross-sectional study, archived sera from 14 patients with active, glucocorticoid-naïve EGPA and 20 with severe eosinophilic asthma without EGPA were profiled on a 2,588-miRNA microarray. Differential expression among 1,777 quantifiable miRNAs was assessed with limma, adjusting for sex and RNA integrity number; significance required both a Benjamini–Hochberg false discovery rate below 0.05 and a Bonferroni-corrected p below 0.05. TargetScan-predicted target genes were intersected with 29 serum proteins previously shown to differ between the same groups. Two further paired analyses, each performed in a separate group of patients with EGPA, compared active disease with the glucocorticoid-treated phase (n = 11) and samples before versus after mepolizumab (n = 13). Results: Eight miRNAs met both criteria: hsa-miR-3126-5p, hsa-miR-921, hsa-miR-6836-5p and hsa-miR-668-5p were lower in EGPA, and hsa-miR-6857-3p, hsa-miR-1260a, hsa-miR-603 and hsa-miR-12125 were higher (within-cohort areas under the curve, 0.82–0.94). Fourteen of the 29 proteins were encoded by predicted target genes. Only hsa-miR-3678-3p changed after glucocorticoid treatment; no miRNA changed after mepolizumab, and none of the eight EGPA-associated miRNAs changed with either treatment. Conclusion: This exploratory study identifies circulating miRNA differences between EGPA and severe eosinophilic asthma, and the complete result table is provided as a reference resource. Independent validation is required to establish their biological and clinical significance. Trial registration: UMIN000040163

International Archives of Allergy and Immunology
Vasculitis and related conditions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon